Update on Diffuse Alveolar Hemorrhage and Pulmonary Vasculitis

Immunology and Allergy Clinics of North America

Volumn 32, Issue 4, 2012, Pages 587-600

  Krause, Megan L ^a   Cartin Ceba, Rodrigo ^a   Specks, Ulrich ^a   Peikert, Tobias ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

ANCA associated vasculitis; Diffuse alveolar hemorrhage; Eosinophilic granulomatosis with polyangiitis; Granulomatosis with polyangiitis; Microscopic polyangiitis; Pulmonary vasculitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB;

ANCA ASSOCIATED VASCULITIS; ANTIPHOSPHOLIPID SYNDROME; BLADDER CANCER; BONE MARROW SUPPRESSION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG MONITORING; FEMALE INFERTILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; LEUKOPENIA; LUNG HEMORRHAGE; MAINTENANCE THERAPY; MALE INFERTILITY; NEUTROPENIA; OPPORTUNISTIC INFECTION; PATIENT CARE; PLASMAPHERESIS; PRIORITY JOURNAL; PULMONARY VASCULITIS; REVIEW; THROMBOSIS; TREATMENT OUTCOME;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; PULMONARY ALVEOLI; VASCULITIS;

EID: 84868005632     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2012.08.001     Document Type: Review

References (59)

1. Travis W.D., Colby T.V., Lombard C., et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990, 14(12):1112-1125.
2. Falk R.J., Gross W.L., Guillevin L., et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum 2011, 63(4):863-864.
3. de Prost N., Parrot A., Picard C., et al. Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J 2010, 35(6):1303-1311.
4. Cordier J.F., Cottin V. Alveolar hemorrhage in vasculitis: primary and secondary. Semin Respir Crit Care Med 2011, 32(3):310-321.
5. Lara A.R., Schwarz M.I. Diffuse alveolar hemorrhage. Chest 2010, 137(5):1164-1171.
6. Castaner E., Alguersuari A., Gallardo X., et al. When to suspect pulmonary vasculitis: radiologic and clinical clues. Radiographics 2010, 30(1):33-53.
7. Hansell D.M. Small-vessel diseases of the lung: CT-pathologic correlates. Radiology 2002, 225(3):639-653.
8. Ewan P.W., Jones H.A., Rhodes C.G., et al. Detection of intrapulmonary hemorrhage with carbon monoxide uptake. Application in Goodpasture's syndrome. N Engl J Med 1976, 295(25):1391-1396.
9. De Lassence A., Fleury-Feith J., Escudier E., et al. Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 1995, 151(1):157-163.
10. Maldonado F., Parambil J.G., Yi E.S., et al. Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage. Eur Respir J 2009, 33(6):1361-1366.
11. Mark E.J., Matsubara O., Tan-Liu N.S., et al. The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis: a study based on 35 open lung biopsies. Hum Pathol 1988, 19(9):1065-1071.
12. Travis W.D., Hoffman G.S., Leavitt R.Y., et al. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991, 15(4):315-333.
13. Watts R., Lane S., Hanslik T., et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007, 66(2):222-227.
14. Rabe C., Appenrodt B., Hoff C., et al. Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care 2010, 25(2):230-235.
15. Papiris S.A., Manali E.D., Kalomenidis I., et al. Bench-to-bedside review: pulmonary-renal syndromes-an update for the intensivist. Crit Care 2007, 11(3):213.
16. Savage C.O., Winearls C.G., Evans D.J., et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985, 56(220):467-483.
17. Serra A., Cameron J.S., Turner D.R., et al. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Med 1984, 53(210):181-207.
18. Guillevin L., Durand-Gasselin B., Cevallos R., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999, 42(3):421-430.
19. Guillevin L., Cohen P., Gayraud M., et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999, 78(1):26-37.
20. Keogh K.A., Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003, 115(4):284-290.
21. Khan S.A., Subla M.R., Behl D., et al. Outcome of patients with small-vessel vasculitis admitted to a medical ICU. Chest 2007, 131(4):972-976.
22. Henke D., Falk R.J., Gabriel D.A. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med 2004, 140(6):493-494.
23. Heslet L., Nielsen J.D., Levi M., et al. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care 2006, 10(6):R177.
24. Pastores S.M., Papadopoulos E., Voigt L., et al. Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa. Chest 2003, 124(6):2400-2403.
25. Hicks K., Peng D., Gajewski J.L. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant 2002, 30(12):975-978.
26. Merkel P.A., Lo G.H., Holbrook J.T., et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) study. Ann Intern Med 2005, 142(8):620-626.
27. Wanko S.O., Broadwater G., Folz R.J., et al. Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid. Biol Blood Marrow Transplant 2006, 12(9):949-953.
28. Hoffman G.S., Kerr G.S., Leavitt R.Y., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116(6):488-498.
29. Talar-Williams C., Hijazi Y.M., Walther M.M., et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 1996, 124(5):477-484.
30. Clowse M.E., Copland S.C., Hsieh T.C., et al. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's). Arthritis Care Res 2011, 63(12):1777-1781.
31. de Groot K., Harper L., Jayne D.R., et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 2009, 150(10):670-680.
32. Harper L., Morgan M.D., Walsh M., et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis 2012, 71(6):955-960.
33. De Groot K., Rasmussen N., Bacon P.A., et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005, 52(8):2461-2469.
34. Klemmer P.J., Chalermskulrat W., Reif M.S., et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003, 42(6):1149-1153.
35. Gallagher H., Kwan J.T., Jayne D.R. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002, 39(1):42-47.
36. Jayne D.R., Gaskin G., Rasmussen N., et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007, 18(7):2180-2188.
37. Szczepiorkowski Z.M., Winters J.L., Bandarenko N., et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apheresis 2010, 25(3):83-177.
38. Plasma exchange and glucocorticoids for treatment of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis. Available at: Accessed May 26, 2012. http://clinicaltrials.gov/ct2/results%3Fterm%3Dpexivas.
39. Specks U., Fervenza F.C., McDonald T.J., et al. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 2001, 44(12):2836-2840.
40. Keogh K.A., Wylam M.E., Stone J.H., et al. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005, 52(1):262-268.
41. Keogh K.A., Ytterberg S.R., Fervenza F.C., et al. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006, 173(2):180-187.
42. Cartin-Ceba R., Golbin J.M., Keogh K.A., et al. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): a single-center ten-year experience. Arthritis Rheum 2012, 10.1002/art.34584.
43. Cartin-Ceba R., Fervenza F.C., Specks U. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab. Curr Opin Rheumatol 2012, 24(1):15-23.
44. Stone J.H., Merkel P.A., Spiera R., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363(3):221-232.
45. Specks U., Stone J.H., Group R.R. Long-term efficacy and safety results of the rave trial. Clin Exp Immunol 2011, 164(Suppl 1):65. [abstract].
46. Jones R.B., Tervaert J.W., Hauser T., et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010, 363(3):211-220.
47. Jayne D., Rasmussen N., Andrassy K., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003, 349(1):36-44.
48. Pagnoux C., Mahr A., Hamidou M.A., et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 2008, 359(26):2790-2803.
49. Langford C.A., Talar-Williams C., Barron K.S., et al. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. Arthritis Rheum 1999, 42(12):2666-2673.
50. Hiemstra T.F., Walsh M., Mahr A., et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA 2010, 304(21):2381-2388.
51. Langford C.A., Talar-Williams C., Sneller M.C. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum 2004, 51(2):278-283.
52. Deane K.D., West S.G. Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum 2005, 35(3):154-165.
53. Waterer G.W., Latham B., Waring J.A., et al. Pulmonary capillaritis associated with the antiphospholipid antibody syndrome and rapid response to plasmapheresis. Respirology 1999, 4(4):405-408.
54. Cartin-Ceba R., Peikert T., Ashrani A., et al. Diffuse alveolar hemorrhage caused by primary antiphospholipid syndrome 2012, [abstract], European Respiratory Society Annual Congress, Vienna (Austria).
55. Scheiman Elazary A., Klahr P.P., Hershko A.Y., et al. Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome. Lupus 2012, 21(4):438-440.
56. Afessa B., Tefferi A., Litzow M.R., et al. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002, 166(5):641-645.
57. Majhail N.S., Parks K., Defor T.E., et al. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Biol Blood Marrow Transplant 2006, 12(10):1038-1046.
58. Afessa B., Abdulai R.M., Kremers W.K., et al. Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant. Chest 2012, 141(2):442-450.
59. Afessa B., Tefferi A., Litzow M.R., et al. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002, 166(10):1364-1368.